A cord blood methylation profile score (MPSBW) built from 835 CpGs previously linked to birthweight in the general population generalizes to a high-risk clinical cohort of 67 monochorionic (MC) twin pairs — 97% born preterm. Within-pair analyses showed that each 500-gram increase in birthweight corresponded to a 0.256 SD rise in MPSBW (p<0.005), and this association held after adjusting for polygenic scores for birthweight, confirming the signal is not merely a proxy for shared genetic architecture or maternal environment.
Monochorionic twins are a near-ideal natural experiment: they share essentially all genetic material and a single placenta, yet often experience unequal nutrient distribution. The within-pair design elegantly strips away familial, maternal, and obstetric confounders that plague conventional epigenetic-birthweight studies. The finding that the epigenetic signal survives this stringent control suggests cord blood methylation captures something genuinely biological about fetal growth — potentially placental nutrient sensing, hypoxia response, or growth-factor signaling pathways — rather than acting as a passive genetic readout.
Practical implications remain speculative at this stage. If validated, MPSBW could inform neonatal risk stratification for growth-restricted preterm infants beyond standard biometrics. Limitations include a modest sample of 134 neonates from one cohort and an exclusively preterm, twin population that limits generalizability to singletons or term births. As a preprint posted to medRxiv and not yet peer-reviewed, the findings require independent replication before clinical translation. Nonetheless, the causal framing is more compelling here than in most observational epigenetic studies.